Effect of Omega Fatty Acids on treatment of Gastric Cancer
Phase 2
- Conditions
- Gastric Adenocarsinoma.Malignant neoplasm of body of stomach
- Registration Number
- IRCT2016121216922N2
- Lead Sponsor
- Tabriz liver and Gastrointestinal Disease research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
patients with gastric adenocarcinoma who that the chemotherapy will be. Exclusion criteria: People who are not taking medication due to cardiac obstruction; Pyloric obstruction due to people who are not able to take medicine; Diabetic patients; Patients with renal failure; Three months before entering the study, patients who are taking omega supplements.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug resistance. Timepoint: before and after. Method of measurement: jen expression and level of protein.
- Secondary Outcome Measures
Name Time Method Oxidative stress. Timepoint: before and after. Method of measurement: jen expression and level of protein.